ReviewCurrent atherosclerosis reports2025
Correlation Between Oral Bacteria and Atherosclerotic Thrombotic Disease: Advances in Animal Model Studies.
Review in Current atherosclerosis reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An oral-gut microbial metabolite linksGut microbes · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purpose of reviewThis review summarizes the current applications of animal models in studying oral bacteria and atherosclerotic thrombotic disease (ATD), providing a reference for future research. RECENT
findingsATD is characterized by plaque formation, rupture, and thrombus aggregation, leading to vascular lumen occlusion or stenosis. It is a major contributor to cardiovascular events, linked to risk factors such as hypertension and hyperlipidemia. Recent studies have focused on the relationship between oral bacteria and ATD, suggesting that oral bacteria and their metabolites contribute to ATD through inflammatory responses, endothelial dysfunction, procoagulant effects, and metabolic changes. Although the correlation between oral bacteria and ATD is established, the underlying molecular mechanisms and signaling pathways remain unclear. Animal models are essential for investigating these mechanisms and replicating pathological processes. However, the lack of standardized methodologies introduces bias. This review provides a comparative analysis of the advantages and limitations associated with animal models of atherosclerosis, arterial thrombosis, combined atherosclerosis and thrombosis, as well as models incorporating oral bacteria in atherosclerotic thrombotic disease. It systematically summarizes animal models of atherosclerotic thrombosis and proposes that, when investigating the interaction between oral bacteria and ATD, both the atherosclerotic thrombosis model and oral bacteria introduction methods may be cross-utilized, depending on specific research requirements. This study proposes a more suitable model: combining a periodontitis model with an atherosclerotic plaque model and using P53 adenovirus to induce controlled plaque rupture.
Indexed as
Identifiers
41026303What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.